PL3843702T4 - Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce - Google Patents

Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce

Info

Publication number
PL3843702T4
PL3843702T4 PL20732664.6T PL20732664T PL3843702T4 PL 3843702 T4 PL3843702 T4 PL 3843702T4 PL 20732664 T PL20732664 T PL 20732664T PL 3843702 T4 PL3843702 T4 PL 3843702T4
Authority
PL
Poland
Prior art keywords
memantine
donepezil
immediate release
fixed dose
release combination
Prior art date
Application number
PL20732664.6T
Other languages
English (en)
Polish (pl)
Other versions
PL3843702T3 (pl
Inventor
Maria Catarina OLIVEIRA MACHUCO ESTEVENS
Ricardo Manuel SILVA MARQUES DA COSTA
João Pedro SILVA SERRA
Augusto Eugénio PARDAL FILIPE
Original Assignee
Tecnimede, Sociedade Técnico-Medicinal, Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede, Sociedade Técnico-Medicinal, Sa filed Critical Tecnimede, Sociedade Técnico-Medicinal, Sa
Priority claimed from PCT/IB2020/055137 external-priority patent/WO2020240505A1/en
Publication of PL3843702T3 publication Critical patent/PL3843702T3/pl
Publication of PL3843702T4 publication Critical patent/PL3843702T4/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL20732664.6T 2019-05-31 2020-05-29 Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce PL3843702T4 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT2019115557 2019-05-31
PCT/IB2020/055137 WO2020240505A1 (en) 2019-05-31 2020-05-29 Immediate release fixed-dose combination of memantine and donepezil

Publications (2)

Publication Number Publication Date
PL3843702T3 PL3843702T3 (pl) 2024-04-08
PL3843702T4 true PL3843702T4 (pl) 2024-04-08

Family

ID=88650785

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20732664.6T PL3843702T4 (pl) 2019-05-31 2020-05-29 Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce

Country Status (7)

Country Link
ES (1) ES2960207T3 (sr)
HU (1) HUE063622T2 (sr)
LT (1) LT3843702T (sr)
MA (1) MA53513B1 (sr)
PL (1) PL3843702T4 (sr)
RS (1) RS64694B1 (sr)
SM (1) SMT202300336T1 (sr)

Also Published As

Publication number Publication date
RS64694B1 (sr) 2023-11-30
PL3843702T3 (pl) 2024-04-08
MA53513B1 (fr) 2023-10-31
ES2960207T3 (es) 2024-03-01
SMT202300336T1 (it) 2023-11-13
MA53513A (fr) 2021-09-08
HUE063622T2 (hu) 2024-01-28
LT3843702T (lt) 2023-11-10

Similar Documents

Publication Publication Date Title
IL283134A (en) Alcohol-resistant drug formulations
EP3686201A4 (en) INFLUENCE VIRUS REPLICATION INHIBITOR AND ITS USES
PL4272834T3 (pl) Zastosowanie terapeutyczne mitochondriów i połączonych środków mitochondrialnych
PT3717471T (pt) Novos compostos e composições farmacêuticas dos mesmos para o tratamento de doenças
EP3565812C0 (en) TUBULIN-BINDING COMPOUNDS AND THEIR THERAPEUTIC USE
PL4335517T3 (pl) Podawanie i dawkowanie diaminofenotiazyn
DK3620174T3 (da) Enhedsdosis af dengue-vaccine og indgivelse deraf
IL258997B (en) Honey-cannabinoid therapeutic composition
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
EP3310376A4 (en) MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
PL3229794T3 (pl) Kombinacja farmaceutyczna obejmująca ponesimod i jej zastosowanie w leczeniu stwardnienia rozsianego
IL269236A (en) Engineered antimicrobial amphiphilic peptides and methods of use
MX2022005372A (es) Combinaciones y formulaciones de dosis fijas que comprenden etc-1002 y una o mas estatinas.
EP3373907A4 (en) RETARD PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
IL290231A (en) Mhc class ii molecules and methods of use thereof
IL282157A (en) Compounds and therapeutic uses thereof
IL290223A (en) Mhc class ii molecules and methods of use thereof
EP3651771C0 (en) RADIATION STERILIZATION OF HYPERCOMPRESSED POLYMER DOSAGE FORMS
EP4034113A4 (en) THERAPEUTIC FORMULATIONS AND THEIR USES
IL312874A (en) Pharmaceutical composition and use thereof
IL269305A (en) Cannabinoid formulations and dosage
IL285765A (en) Therapeutic uses of dulaglutide
MA43114A (fr) Formulation combinée à dose fixe d'éflornithine et sulindac
HUE066977T2 (hu) Pán-genotípusos ágensek influenzavírus ellen és azok alkalmazási eljárása
MX2017011904A (es) Composiciones para el tratamiento de fibrosis y afecciones relacionadas con fibrosis.